www.fdanews.com/articles/146282-glaxosmithkline-in-takeover-bid-for-human-genome
GlaxoSmithKline in Takeover Bid for Human Genome
May 9, 2012
GlaxoSmithKline has tabled an offer to take over U.S. drugmaker Human Genome Sciences which values the target at nearly $2.6 billion.
The Kansas City Star
The Kansas City Star